Trial
NCT03431272
Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
Shire
Condition
Contact Lens Dry Eye
Intervention
Lifitegrast
Why stopped
no longer interest / resources to start study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-25